Follow
Tasnim Nafisa
Tasnim Nafisa
National Institute of Laboratory Medicine and Referral Centre
Verified email at ld.dghs.gov.bd
Title
Cited by
Cited by
Year
SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts
MN Hoque, MMH Sarkar, MS Rahman, S Akter, TA Banu, B Goswami, ...
Scientific reports 11 (1), 24042, 2021
402021
Antibiotic prescribing patterns at COVID-19 dedicated wards in Bangladesh: Findings from a single center study
MMA Molla, M Yeasmin, MK Islam, MM Sharif, MR Amin, T Nafisa, ...
Infection prevention in practice 3 (2), 100134, 2021
372021
Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches
MN Hoque, MMH Sarkar, MA Khan, MA Hossain, MI Hasan, MH Rahman, ...
Frontiers in immunology 13, 918692, 2022
162022
Evidences on irrational anti-microbial prescribing and consumption among COVID-19 positive patients and possible mitigation strategies: a descriptive cross sectional study.
M Parveen, MMA Molla, M Yeasmin, T Nafisa, AA Barna, AK Ghosh
142020
Coding-complete genome sequences of three SARS-CoV-2 strains from Bangladesh
S Akter, TA Banu, B Goswami, E Osman, MS Uzzaman, MA Habib, ...
Microbiology resource announcements 9 (39), 10.1128/mra. 00764-20, 2020
142020
Decreasing transmission and initiation of countrywide vaccination: Key challenges for future management of COVID‐19 pandemic in Bangladesh
MMA Molla, JA Disha, M Yeasmin, AK Ghosh, T Nafisa
The International Journal of Health Planning and Management 36 (4), 1014-1029, 2021
132021
Molecular and serological characterization of the SARS-CoV-2 delta variant in Bangladesh in 2021
AK Ghosh, M Kaiser, MMA Molla, T Nafisa, M Yeasmin, RH Ratul, ...
Viruses 13 (11), 2310, 2021
102021
Clinical presentation of COVID-19 and antibody responses in Bangladeshi patients infected with the Delta or Omicron variants of SARS-CoV-2
AK Ghosh, O Landt, M Yeasmin, M Sharif, RH Ratul, MA Molla, T Nafisa, ...
Vaccines 10 (11), 1959, 2022
72022
Genome sequencing of the SARS-CoV-2 Delta (B. 1.617. 2) variant of concern detected in Bangladesh
TA Banu, MMH Sarkar, S Akter, B Goswami, I Jahan, E Osman, ...
Microbiology Resource Announcements 10 (48), e00849-21, 2021
72021
Detection of anti-nucleocapsid antibody in COVID-19 patients in Bangladesh is not correlated with previous dengue infection
SD Lytton, M Yeasmin, AK Ghosh, MRH Bulbul, MMA Molla, M Herr, ...
Pathogens 10 (6), 637, 2021
62021
Demographic characteristics of 1082 positive cases of COVID-19 patients: experience at national referral laboratory of Bangladesh.
A Akram, M Yeasmin, THME Ullah Khan, MAA Zubayer Khan, ...
42020
Genome sequencing and genetic characterization of 17 SARS-CoV-2 viruses and spike protein analyses of isolates from Bangladeshi patients
S Akter, TA Banu, B Goswami, I Jahan, E Osman, MS Uzzaman, ...
32021
Spike protein mutations and structural insights of pangolin lineage B. 1.1. 25 with implications for viral pathogenicity and ACE2 binding affinity
S Akter, JIN Oliveira, C Barton, MH Sarkar, M Shahab, TA Banu, ...
Scientific Reports 13 (1), 13146, 2023
22023
Knowledge, attitude and practices toward COVID-19 among healthcare workers in National Institute of Laboratory Medicine and Referral Center, Dhaka, Bangladesh
A Akram, MMA Molla, M Yeasmin, T Nafisa, MBB Monir, J Islam, A Mamun, ...
Microbes and Infectious Diseases 2 (3), 433-439, 2021
22021
A Review on D 614G Mutation with Bangladesh Scenario
A Akram, MJR Khan, MBB Monir, MRU Chowdhury, M Yeasmin, ...
Advances in Infectious Diseases 10 (3), 249-255, 2020
22020
Emergence of SARS-CoV-2 variant of interest B. 1.525 (Eta) in Bangladesh
B Goswami, MMH Sarkar, S Akter, TA Banu, I Jahan, MS Hossain, ...
Biologicals 84, 101714, 2023
12023
HIV‐1 molecular epidemiology in Bangladesh: A systematic review
MMA Molla, M Yeasmin, AK Ghosh, T Nafisa, MK Islam, ...
Health Science Reports 4 (3), e344, 2021
12021
Antibiotic prescribing patterns at COVID-19 dedicated wards in Bangladesh: a single center point-prevalence survey
MMA Molla, M Yeasmin, MK Islam, MM Sharif, MR Amin, T Nafisa, ...
medRxiv, 2021.01. 15.21249868, 2021
12021
Evidences on irrational anti-microbial prescribing and consumption among COVID-19 positive patients and possible mitigation strategies: a descriptive cross sectional study …
P Monira, MMA Molla, Y Mahmuda, N Tasnim, AA Barna, AK Ghosh
Bangladesh Journal of Infectious Diseases, S3-S7, 2020
12020
Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh
L Carnegie, J McCrone, L Du Plessis, M Hasan, MZ Ali, R Begum, ...
medRxiv, 2024.05. 07.24306987, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20